Corrigendum to "Beta cell specific cannabinoid 1 receptor deletion counteracts progression to hyperglycemia in non-obese diabetic mice" [Mol Metab 82 (2024 April) 101906].
作者信息
Aseer Kanikkai Raja, Mazucanti Caio Henrique, O'Connell Jennifer F, González-Mariscal Isabel, Verma Anjali, Yao Qin, Dunn Christopher, Liu Qing-Rong, Egan Josephine M, Doyle Máire E
机构信息
Laboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA; Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Laboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA.
出版信息
Mol Metab. 2024 Apr;82:101917. doi: 10.1016/j.molmet.2024.101917. Epub 2024 Mar 16.
Abstract
摘要
相似文献
1
Corrigendum to "Beta cell specific cannabinoid 1 receptor deletion counteracts progression to hyperglycemia in non-obese diabetic mice" [Mol Metab 82 (2024 April) 101906].
Mol Metab. 2024 Apr;82:101917. doi: 10.1016/j.molmet.2024.101917. Epub 2024 Mar 16.
2
Beta cell specific cannabinoid 1 receptor deletion counteracts progression to hyperglycemia in non-obese diabetic mice.
Mol Metab. 2024 Apr;82:101906. doi: 10.1016/j.molmet.2024.101906. Epub 2024 Feb 28.
3
Corrigendum to "Inter-domain tagging implicates caveolin-1 in insulin receptor trafficking and Erk signaling bias in pancreatic beta-cells" [Mol Metab 2016 May; 5 (5): 366-378].
Mol Metab. 2024 May;83:101935. doi: 10.1016/j.molmet.2024.101935. Epub 2024 Apr 8.
4
Rimonabant, a cannabinoid CB1 receptor antagonist, attenuates mechanical allodynia and counteracts oxidative stress and nerve growth factor deficit in diabetic mice.
Eur J Pharmacol. 2010 Jul 10;637(1-3):62-9. doi: 10.1016/j.ejphar.2010.03.061. Epub 2010 Apr 14.
5
Corrigendum to "First contiguous gene deletion causing biotinidase deficiency: The enzyme deficiency in three Sri Lankan children" [Mol. Genet. Metab. Rep. 2 (2016) 81-84].
Mol Genet Metab Rep. 2016 Apr 12;11:95. doi: 10.1016/j.ymgmr.2016.04.001. eCollection 2017 Jun.
6
7
Corrigendum to "Molecular regulation of urea cycle function by the liver glucocorticoid receptor" [Mol Metab 4 (10) (2015 Oct) 732-740].
Mol Metab. 2020 Nov;41:101068. doi: 10.1016/j.molmet.2020.101068. Epub 2020 Sep 5.
8
Corrigendum to "Metabolic adaptation to intermittent fasting is independent of peroxisome proliferator-activated receptor alpha" [Mol Metab 7 (2018) 80-89].
Mol Metab. 2018 Mar;9:217-219. doi: 10.1016/j.molmet.2018.01.008. Epub 2018 Feb 2.
9
Corrigendum to "In vitro evaluation of 2-hydroxyalkylated β-cyclodextrins as potential therapeutic agents for Niemann-pick type C disease" [Mol. Genet. Metab. (2016) 214-219].
Mol Genet Metab. 2017 Mar;120(3):296-297. doi: 10.1016/j.ymgme.2016.09.004. Epub 2016 Oct 10.
10
Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type 2 Diabetes.
Diabetes. 2017 Apr;66(4):994-1007. doi: 10.2337/db16-1199. Epub 2017 Jan 12.
引用本文的文献
1
Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans.
Diabetologia. 2024 Sep;67(9):1877-1896. doi: 10.1007/s00125-024-06193-6. Epub 2024 Jun 12.
Zotero 插件